FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Drug-Eluting Peripheral Transluminal Angioplasty Catheter

PMA: P140010 · Supplement: S102 · Decision Apr 23, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Basic Information

Device Name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Trade Name
IN.PACT Admiral Paclitaxel-Coated Percutaneous Transluminal Angioplasty Balloon Catheter; IN.PACT 018 Paclitaxel-Coated
PMA Number
P140010
Supplement Number
S102
Device Class
FDA Class 3
Product Code
ONU
Generic Name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
April 23, 2026
Date Received
March 25, 2026
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

the implementation of an ultraviolet (UV) filter in the water trough system

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
ONU Drug-Eluting Peripheral Transluminal Angioplasty Catheter